Molecular characterization of woodchuck type I interferons and their expression by woodchuck peripheral blood lymphocytes - PubMed

Molecular characterization of woodchuck type I interferons and their expression by woodchuck peripheral blood lymphocytes

Yinping Lu et al. Cytokine. 2008 Feb.

Abstract

Interferon (IFN)-alpha and -beta are important antiviral mediators. IFN-alpha is widely used for the treatment of chronic hepatitis B. In our previous studies, a subtype of woodchuck IFN-alpha (wIFN-alpha) was characterized and has been shown to be active in suppressing the replication of woodchuck hepatitis virus (WHV) in vitro and vivo. Here, we refined the analysis of the IFN-alpha/beta system of the woodchuck and studied the expression of wIFN-alpha/beta in peripheral blood lymphocytes (PBLs) from naïve and WHV-infected woodchucks. A number of wIFN-alpha genes were sequenced and could be classified into 10 subtypes and 3 pseudotypes. The biological activity of different subtypes of wIFN-alpha was demonstrated by their ability to protect woodchuck cells against encephalomyocarditis virus infection and to induce MxA expression in woodchuck cells. Additionally, a partial sequence of wIFN-beta was characterized. A subtyping method for wIFN-alpha based on restriction length polymorphism analysis was developed. Further, the expression of wIFN by woodchuck PBLs after stimulation with polyI/C was investigated. The maximal production of wIFN by woodchuck PBLs occurred within the first 48 h after addition poly I/C. The wIFN-alpha subtypes 1, 4, and 5 were found to be produced by poly I/C-stimulated woodchuck PBLs, indicating a selective expression of wIFN-alpha subtypes. PBLs from chronically WHV-infected woodchucks showed a reduced ability to produce wIFN when stimulated with poly I/C. The results suggest that woodchucks with chronic WHV infection have impaired immunological responses to poly I/C.

Similar articles

• Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.

  Fiedler M, Rödicker F, Salucci V, Lu M, Aurisicchio L, Dahmen U, Jun L, Dirsch O, Pützer BM, Palombo F, Roggendorf M. Fiedler M, et al. J Virol. 2004 Sep;78(18):10111-21. doi: 10.1128/JVI.78.18.10111-10121.2004. J Virol. 2004. PMID: 15331744 Free PMC article.

• Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.

  Lu M, Hilken G, Yang D, Kemper T, Roggendorf M. Lu M, et al. J Virol. 2001 Apr;75(8):3811-8. doi: 10.1128/JVI.75.8.3811-3818.2001. J Virol. 2001. PMID: 11264370 Free PMC article.

• Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.

  Roggendorf M, Schulte I, Xu Y, Lu M. Roggendorf M, et al. J Viral Hepat. 2007 Nov;14 Suppl 1:51-7. doi: 10.1111/j.1365-2893.2007.00914.x. J Viral Hepat. 2007. PMID: 17958643 Review.

• Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.

  Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, Picard C, Abel L, Jouanguy E, Casanova JL. Zhang SY, et al. Immunol Rev. 2008 Dec;226:29-40. doi: 10.1111/j.1600-065X.2008.00698.x. Immunol Rev. 2008. PMID: 19161414 Review.

Cited by

• Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B.

  Fletcher SP, Chin DJ, Gruenbaum L, Bitter H, Rasmussen E, Ravindran P, Swinney DC, Birzele F, Schmucki R, Lorenz SH, Kopetzki E, Carter J, Triyatni M, Thampi LM, Yang J, AlDeghaither D, Murreddu MG, Cote P, Menne S. Fletcher SP, et al. PLoS Pathog. 2015 Sep 9;11(9):e1005103. doi: 10.1371/journal.ppat.1005103. eCollection 2015 Sep. PLoS Pathog. 2015. PMID: 26352406 Free PMC article.

• Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.

  Zhang E, Lu M. Zhang E, et al. Med Microbiol Immunol. 2015 Feb;204(1):11-20. doi: 10.1007/s00430-014-0370-1. Epub 2014 Dec 31. Med Microbiol Immunol. 2015. PMID: 25550115 Free PMC article. Review.

• IFN-α subtypes: distinct biological activities in anti-viral therapy.

  Gibbert K, Schlaak JF, Yang D, Dittmer U. Gibbert K, et al. Br J Pharmacol. 2013 Mar;168(5):1048-58. doi: 10.1111/bph.12010. Br J Pharmacol. 2013. PMID: 23072338 Free PMC article. Review.

• Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck.

  Kosinska AD, Liu J, Lu M, Roggendorf M. Kosinska AD, et al. Med Microbiol Immunol. 2015 Feb;204(1):103-14. doi: 10.1007/s00430-014-0379-5. Epub 2014 Dec 23. Med Microbiol Immunol. 2015. PMID: 25535101 Free PMC article. Review.

• The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.

  Roggendorf M, Kosinska AD, Liu J, Lu M. Roggendorf M, et al. Cold Spring Harb Perspect Med. 2015 Oct 28;5(12):a021451. doi: 10.1101/cshperspect.a021451. Cold Spring Harb Perspect Med. 2015. PMID: 26511761 Free PMC article. Review.

Publication types

MeSH terms

Substances